Trial intelligence / Profile preview

Automatic Remifentanil Administration Guided by the Analgesia Nociception Index During Propofol Anesthesia

NCT03556696Completed

Sponsor
CHU de Lille
Start
Jun 2018
Primary completion
Jun 2022
Countries
1
01

Overview

Randomised trial (2 arms), sponsored by CHU de Lille. Primary endpoint: Overall normalized remifentanil administration. Started Jun 2018; status: completed.

Beyond the preview

Go deeper on NCT03556696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03556696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call